Biosyntia
PrivateLast Round
Series B
Extension
Sep 29, 2022
Total Funding Raised
$24.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biosyntia is a biotechnology company that develops and produces natural active ingredients, such as vitamins, through sustainable fermentation processes for the nutrition and beauty industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosyntia Comparables
Compare Biosyntia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amyris | 83% | |
| Cellibre | 81% | |
| Conagen | 80% | |
Biosyntia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 29, 2022 | ||||
| Series B | Jul 6, 2022 | ||||
| Series A | Apr 24, 2018 | ||||
| Seed | May 21, 2015 | ||||
| Grant | Jun 1, 2013 | ||||
Grant | Jun 1, 2012 |
Biosyntia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Holdings | Series B Extension, Series B, Grant, Series A, Seed |
| Praesidium | Series B Extension |
| The Export and Investment Fund of Denmark | Series B Extension |
| Sofinnova Partners | Series B Extension, Series B, Series A |
| ECBF Management | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 179% MoM, reaching 2K.
- May 4, 2025
Monthly visitors grew 496% MoM.
Biosyntia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biosyntia's valuation, stock price, and market status.